Search Results 841-850 of 17868 for Assay

  1. Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML - Mayo Clinic

    * Participants with newly diagnosed AML with FLT3-ITD mutations (FLT3-ITD \[+\]) present at ≥5% VAF (or ≥0.05 SR) based on a validated FLT3 mutation assay.

  2. Science Saturday: Quest to unmask an elusive immune cancer - Mayo Clinic News Network

    The test uses a 20-gene expression-based assay to establish where a patient's lymphoma started. That “cell-of-origin” information helps determine the ...

  3. A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma - Mayo Clinic

    NOTE: Bone marrow aspirate specimen must be submitted to Adaptive Biotechnologies for clonoSEQ Assay. NOTE: Adaptive Biotechnologies will release results to ...

  4. Clinical trials - Oncology (Medical)

    ... assays using patient peripheral blood immune cells or serum. Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal ...

  5. Alzheimer's biomarker testing: Boosting diagnostic accuracy so that patients can plan for the future - Mayo Clinic

    The test includes CSF assays for beta-amyloid, total tau and phosphorylated tau. Although beta-amyloid can be detected with positron emission tomography ...

  6. Screening Study For KIT D816V Mutated Mast Cell Disease In Select Populations - Mayo Clinic

    No more than 1 prior result of “not detected” was obtained using a high-sensitivity assay (LOD ≤ 0.03%) and. Baseline serum tryptase level is elevated ...

  7. Publications - Nathanael G. Bailey, M.D. - Mayo Clinic

    Visualization of the Effect of Assay Size on the Error Profile of Tumor Mutational Burden Measurement. ... assays. Appl Immunohistochem Mol Morphol. 2015 ...

  8. Clinical trials - Oncology (Medical)

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  9. Pemigatinib trial seeks to build on targeted advances in cholangiocarcinoma - Mayo Clinic

    The assay is a next-generation sequencing device that detects alterations in 324 genes using DNA isolated from formalin-fixed paraffin-embedded tumor tissue ...

  10. Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) - Mayo Clinic

    ... assay; these patients will also have been registered to A151216, but can be enrolled on A081105 regardless of the central lab results. Patients with known ...